• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓来源的间充质基质细胞通过NF-kB、Smad3和Akt信号通路使主动脉瘤消退。

Bone marrow-derived mesenchymal stromal cells regress aortic aneurysm via the NF-kB, Smad3 and Akt signaling pathways.

作者信息

Yamawaki-Ogata Aika, Oshima Hideki, Usui Akihiko, Narita Yuji

机构信息

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Cytotherapy. 2017 Oct;19(10):1167-1175. doi: 10.1016/j.jcyt.2017.07.010. Epub 2017 Aug 31.

DOI:10.1016/j.jcyt.2017.07.010
PMID:28864290
Abstract

BACKGROUND AIMS

We have confirmed that aortic aneurysm (AA) can be regressed by the administration of bone marrow-derived mesenchymal stromal cells (BM-MSCs). We investigated the kinetics of signaling pathways in AA following treatment with BM-MSCs.

METHODS

Angiotensin II-infused apolipoprotein E-deficient mice were treated by intravenous injection of 1 × 10 BM-MSCs in 0.2 mL saline (BM-MSCs group, n = 5) or 0.2 mL saline (saline group, n = 5). Mice were sacrificed 2 weeks after injection and subjected to measurements of the incidence of AA and levels of phosphorylated proteins. Levels of proteins in conditioned media of BM-MSCs were also measured.

RESULTS

The incidence of AA in the BM-MSCs group was reduced (BM-MSC 40% versus saline 100%, P <0.05). Levels of pNF-kB and pSTAT1 were reduced (pNF-kB: 0.28 versus 0.45 unit/mL, P <0.05, pSTAT1: 0.16 versus 0.34, P <0.05), whereas levels of pAkt and pSmad3 were elevated (pAkt: 0.13 versus 0.07, P <0.01, pSmad3: 1.07 versus 0.47, P <0.05) in the BM-MSCs group. The levels of pNF-kB, pAkt, and pSmad3 were correlated with aortic diameters. Trophic factors including IGFPB-3, NRF, Activin A and PDGF-AA were secreted from BM-MSCs (IGFBP-3: 35.2 pg/mL, NRF: 3.1 pg/mL, Activin A: 3.1 pg/mL, PDGF-AA: 0.45 pg/mL).

CONCLUSIONS

Our findings suggested that the therapeutic mechanism of BM-MSC-mediated AA regression could contribute to regulation of the NF-kB, Smad3 and Akt signaling pathways. In addition, paracrine actions by factors including NRF, IGFBP-3, Activin A and PDGF-AA might have affected these signaling pathways.

摘要

背景与目的

我们已证实,给予骨髓间充质基质细胞(BM-MSCs)可使主动脉瘤(AA)消退。我们研究了用BM-MSCs治疗后AA中信号通路的动力学。

方法

通过静脉注射0.2 mL盐水中的1×10 BM-MSCs(BM-MSCs组,n = 5)或0.2 mL盐水(盐水组,n = 5)来治疗血管紧张素II注入的载脂蛋白E缺陷小鼠。注射后2周处死小鼠,测量AA的发生率和磷酸化蛋白水平。还测量了BM-MSCs条件培养基中的蛋白水平。

结果

BM-MSCs组中AA的发生率降低(BM-MSCs组为40%,盐水组为100%,P <0.05)。BM-MSCs组中pNF-kB和pSTAT1水平降低(pNF-kB:0.28对0.45单位/毫升,P <0.05,pSTAT1:0.16对0.34,P <0.05),而pAkt和pSmad3水平升高(pAkt:0.13对0.07,P <0.01,pSmad3:1.07对0.47,P <0.05)。pNF-kB、pAkt和pSmad3水平与主动脉直径相关。BM-MSCs分泌包括IGFPB-3、NRF、激活素A和血小板衍生生长因子AA(PDGF-AA)在内的营养因子(IGFBP-3:35.2 pg/mL,NRF:3.1 pg/mL,激活素A:3.1 pg/mL,PDGF-AA:0.45 pg/mL)。

结论

我们的研究结果表明,BM-MSC介导的AA消退的治疗机制可能有助于调节NF-kB、Smad3和Akt信号通路。此外,包括NRF、IGFBP-3、激活素A和PDGF-AA在内的因子的旁分泌作用可能影响了这些信号通路。

相似文献

1
Bone marrow-derived mesenchymal stromal cells regress aortic aneurysm via the NF-kB, Smad3 and Akt signaling pathways.骨髓来源的间充质基质细胞通过NF-kB、Smad3和Akt信号通路使主动脉瘤消退。
Cytotherapy. 2017 Oct;19(10):1167-1175. doi: 10.1016/j.jcyt.2017.07.010. Epub 2017 Aug 31.
2
Therapeutic potential of bone marrow-derived mesenchymal stem cells in formed aortic aneurysms of a mouse model.骨髓间充质干细胞在小鼠模型形成的主动脉瘤中的治疗潜力。
Eur J Cardiothorac Surg. 2014 May;45(5):e156-65. doi: 10.1093/ejcts/ezu018. Epub 2014 Feb 18.
3
Mesenchymal stem cell-derived conditioned medium attenuate angiotensin II-induced aortic aneurysm growth by modulating macrophage polarization.间质干细胞衍生的条件培养液通过调节巨噬细胞极化来减轻血管紧张素 II 诱导的主动脉瘤生长。
J Cell Mol Med. 2019 Dec;23(12):8233-8245. doi: 10.1111/jcmm.14694. Epub 2019 Oct 4.
4
Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse.静脉注射间充质干细胞可预防载脂蛋白 E 缺陷型小鼠血管紧张素 II 诱导的主动脉瘤形成。
J Transl Med. 2013 Jul 22;11:175. doi: 10.1186/1479-5876-11-175.
5
Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.感染表达核心蛋白聚糖腺病毒的功能增强间充质干细胞对肝纤维化的影响
Stem Cells Transl Med. 2016 Sep;5(9):1247-56. doi: 10.5966/sctm.2015-0323. Epub 2016 Jun 30.
6
Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury.骨髓间充质干细胞通过PI3K/AKT信号通路增强自噬,以减轻缺血/再灌注诱导的肺损伤的严重程度。
J Cell Mol Med. 2015 Oct;19(10):2341-51. doi: 10.1111/jcmm.12638. Epub 2015 Jul 14.
7
Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments.富血小板血浆凝块释放物预处理诱导的 PI3K/AKT/NFκB 信号增强了大鼠骨髓间充质干细胞在恶劣微环境中的存活和再生功能。
Stem Cells Dev. 2013 Dec 15;22(24):3236-51. doi: 10.1089/scd.2013.0064. Epub 2013 Aug 30.
8
Bone marrow mesenchymal stromal cells ameliorate angiogenesis and renal damage via promoting PI3k-Akt signaling pathway activation in vivo.骨髓间充质基质细胞通过促进体内PI3k-Akt信号通路激活来改善血管生成和肾损伤。
Cytotherapy. 2016 Jul;18(7):838-45. doi: 10.1016/j.jcyt.2016.03.300. Epub 2016 May 17.
9
Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice.间质干细胞减轻载脂蛋白 E 缺陷型小鼠血管紧张素 II 诱导的主动脉瘤生长。
J Vasc Surg. 2011 Dec;54(6):1743-52. doi: 10.1016/j.jvs.2011.06.109. Epub 2011 Sep 9.
10
Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.骨髓间充质基质细胞(BM-MSCs)和富含血小板的血浆(PRP)的联合使用可刺激体外成肌细胞的增殖和分化:骨骼肌修复/再生的新治疗前景。
Cell Tissue Res. 2018 Jun;372(3):549-570. doi: 10.1007/s00441-018-2792-3. Epub 2018 Feb 5.

引用本文的文献

1
Administration of a recombinant secretory leukocyte protease inhibitor prevents aortic aneurysm growth in mice.给予重组分泌型白细胞蛋白酶抑制剂可预防小鼠主动脉瘤的生长。
Mol Cell Biochem. 2025 Aug 29. doi: 10.1007/s11010-025-05374-0.
2
A Single Injection of ADRCs Does Not Prevent AAA Formation in Rats in a Randomized Blinded Design.随机盲法设计中单次注射 ADRCs 不能预防大鼠 AAA 的形成。
Int J Mol Sci. 2024 Jul 10;25(14):7591. doi: 10.3390/ijms25147591.
3
Overcoming big bottlenecks in vascular regeneration.克服血管再生中的重大瓶颈。
Commun Biol. 2024 Jul 18;7(1):876. doi: 10.1038/s42003-024-06567-x.
4
A review of current status of cell-based therapies for aortic aneurysms.基于细胞疗法治疗主动脉瘤的现状综述。
Inflamm Regen. 2023 Aug 7;43(1):40. doi: 10.1186/s41232-023-00280-8.
5
Stem Cell Based Approaches to Modulate the Matrix Milieu in Vascular Disorders.基于干细胞的方法调节血管疾病中的基质环境
Front Cardiovasc Med. 2022 Jun 15;9:879977. doi: 10.3389/fcvm.2022.879977. eCollection 2022.
6
Mesenchymal stem/stromal cell-based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19.基于间充质干/基质细胞的COVID-19治疗方法:实时系统评价与荟萃分析的首次迭代:间充质干细胞与COVID-19
Cytotherapy. 2022 Jun;24(6):639-649. doi: 10.1016/j.jcyt.2021.12.001. Epub 2022 Jan 31.
7
Therapeutic efficacy of mesenchymal stem cells for abdominal aortic aneurysm: a meta-analysis of preclinical studies.间充质干细胞治疗腹主动脉瘤的疗效:临床前研究的荟萃分析。
Stem Cell Res Ther. 2022 Feb 24;13(1):81. doi: 10.1186/s13287-022-02755-w.
8
Circulating soluble receptor of advanced glycation end product is associated with bicuspid aortic aneurysm progression via NF-κB pathway.循环中晚期糖基化终产物的可溶性受体通过 NF-κB 途径与二叶式主动脉瘤的进展相关。
Interact Cardiovasc Thorac Surg. 2022 Jan 18;34(2):274-282. doi: 10.1093/icvts/ivab242.